APO Research
Talk to an analyst

APO RESEARCH · REPORT

Aprepitant

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Aprepitant Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025188 pages

Choose your research edition.

Industry ResearchAprepitant Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Aprepitant Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Aprepitant Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Aprepitant Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Aprepitant Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Aprepitant market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Aprepitant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Aprepitant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Aprepitant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Aprepitant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Aprepitant include Shanghai Yingrui Biomedical Technology Co., Ltd., Sandoz, Merck & Co., Vea Impex (I) Pvt. Ltd., Heron Therapeutics, Glenmark Pharmaceuticals, Aetos Pharma, Actiza Pharmaceutical and Aark Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Aprepitant market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Aprepitant and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Aprepitant sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Aprepitant market size, projected growth trends, production technologies, key applications, and end-use industries.

Aprepitant Segment by Company

Shanghai Yingrui Biomedical Technology Co., Ltd.

Sandoz

Merck & Co.

Vea Impex (I) Pvt. Ltd.

Heron Therapeutics

Glenmark Pharmaceuticals

Aetos Pharma

Actiza Pharmaceutical

Aark Pharmaceuticals

Aprepitant Segment by Type

Injection

Oral

Aprepitant Segment by Application

Hospital

Drug store

Aprepitant Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aprepitant market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Aprepitant and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aprepitant.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Aprepitant market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Aprepitant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Aprepitant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Aprepitant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Aprepitant Industry Trends Table 2. Aprepitant Industry Drivers Table 3. Aprepitant Industry Opportunities and Challenges Table 4. Aprepitant Industry Restraints Table 5. Global Aprepitant Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Aprepitant Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Aprepitant Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Aprepitant Sales Market Share by Manufacturers Table 9. Global Aprepitant Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Aprepitant Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Aprepitant Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Aprepitant Manufacturers, Product Type & Application Table 13. Global Aprepitant Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Aprepitant by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Injection Table 17. Major Manufacturers of Oral Table 18. Global Aprepitant Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Aprepitant Sales by Type (2021-2026) & (k units) Table 20. Global Aprepitant Sales by Type (2027-2032) & (k units) Table 21. Global Aprepitant Sales Market Share by Type (2021-2026) Table 22. Global Aprepitant Sales Market Share by Type (2027-2032) Table 23. Global Aprepitant Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Aprepitant Revenue by Type (2021-2026) & (k units) Table 25. Global Aprepitant Revenue by Type (2027-2032) & (k units) Table 26. Global Aprepitant Revenue Market Share by Type (2021-2026) Table 27. Global Aprepitant Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Drug store Table 30. Global Aprepitant Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Aprepitant Sales by Application (2021-2026) & (k units) Table 32. Global Aprepitant Sales by Application (2027-2032) & (k units) Table 33. Global Aprepitant Sales Market Share by Application (2021-2026) Table 34. Global Aprepitant Sales Market Share by Application (2027-2032) Table 35. Global Aprepitant Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Aprepitant Revenue by Application (2021-2026) & (k units) Table 37. Global Aprepitant Revenue by Application (2027-2032) & (k units) Table 38. Global Aprepitant Revenue Market Share by Application (2021-2026) Table 39. Global Aprepitant Revenue Market Share by Application (2027-2032) Table 40. Global Aprepitant Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Aprepitant Sales by Region (2021-2026) & (k units) Table 42. Global Aprepitant Sales Market Share by Region (2021-2026) Table 43. Global Aprepitant Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Aprepitant Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Aprepitant Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Aprepitant Sales by Country (2021-2026) & (k units) Table 47. North America Aprepitant Sales by Country (2027-2032) & (k units) Table 48. Europe Aprepitant Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Aprepitant Sales by Country (2021-2026) & (k units) Table 50. Europe Aprepitant Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Aprepitant Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Aprepitant Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Aprepitant Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Aprepitant Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Aprepitant Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Aprepitant Sales by Country (2027-2032) & (k units) Table 57. Global Aprepitant Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Aprepitant Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Aprepitant Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Aprepitant Revenue Market Share by Region (2021-2026) Table 61. Global Aprepitant Revenue Market Share by Region (2027-2032) Table 62. Shanghai Yingrui Biomedical Technology Co., Ltd. Company Information Table 63. Shanghai Yingrui Biomedical Technology Co., Ltd. Business Overview Table 64. Shanghai Yingrui Biomedical Technology Co., Ltd. Aprepitant Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Shanghai Yingrui Biomedical Technology Co., Ltd. Aprepitant Product Portfolio Table 66. Shanghai Yingrui Biomedical Technology Co., Ltd. Recent Development Table 67. Sandoz Company Information Table 68. Sandoz Business Overview Table 69. Sandoz Aprepitant Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Sandoz Aprepitant Product Portfolio Table 71. Sandoz Recent Development Table 72. Merck & Co. Company Information Table 73. Merck & Co. Business Overview Table 74. Merck & Co. Aprepitant Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Merck & Co. Aprepitant Product Portfolio Table 76. Merck & Co. Recent Development Table 77. Vea Impex (I) Pvt. Ltd. Company Information Table 78. Vea Impex (I) Pvt. Ltd. Business Overview Table 79. Vea Impex (I) Pvt. Ltd. Aprepitant Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Vea Impex (I) Pvt. Ltd. Aprepitant Product Portfolio Table 81. Vea Impex (I) Pvt. Ltd. Recent Development Table 82. Heron Therapeutics Company Information Table 83. Heron Therapeutics Business Overview Table 84. Heron Therapeutics Aprepitant Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Heron Therapeutics Aprepitant Product Portfolio Table 86. Heron Therapeutics Recent Development Table 87. Glenmark Pharmaceuticals Company Information Table 88. Glenmark Pharmaceuticals Business Overview Table 89. Glenmark Pharmaceuticals Aprepitant Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Glenmark Pharmaceuticals Aprepitant Product Portfolio Table 91. Glenmark Pharmaceuticals Recent Development Table 92. Aetos Pharma Company Information Table 93. Aetos Pharma Business Overview Table 94. Aetos Pharma Aprepitant Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Aetos Pharma Aprepitant Product Portfolio Table 96. Aetos Pharma Recent Development Table 97. Actiza Pharmaceutical Company Information Table 98. Actiza Pharmaceutical Business Overview Table 99. Actiza Pharmaceutical Aprepitant Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Actiza Pharmaceutical Aprepitant Product Portfolio Table 101. Actiza Pharmaceutical Recent Development Table 102. Aark Pharmaceuticals Company Information Table 103. Aark Pharmaceuticals Business Overview Table 104. Aark Pharmaceuticals Aprepitant Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Aark Pharmaceuticals Aprepitant Product Portfolio Table 106. Aark Pharmaceuticals Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Aprepitant Distributors List Table 110. Aprepitant Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Aprepitant Product Image Figure 2. Global Aprepitant Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Aprepitant Market Size (2021-2032) & (US$ Million) Figure 4. Global Aprepitant Sales (2021-2032) & (k units) Figure 5. Global Aprepitant Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Aprepitant Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Injection Image Figure 9. Oral Image Figure 10. Global Aprepitant Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Aprepitant Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Aprepitant Sales Market Share by Type (2021-2032) Figure 13. Global Aprepitant Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Aprepitant Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Aprepitant Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Drug store Image Figure 18. Global Aprepitant Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Aprepitant Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Aprepitant Sales Market Share by Application (2021-2032) Figure 21. Global Aprepitant Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Aprepitant Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Aprepitant Revenue Market Share by Application (2021-2032) Figure 24. North America Aprepitant Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Aprepitant Sales Market Share by Country (2021-2032) Figure 26. U.S. Aprepitant Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Aprepitant Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Aprepitant Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Aprepitant Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Aprepitant Sales Market Share by Country (2021-2032) Figure 31. Germany Aprepitant Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Aprepitant Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Aprepitant Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Aprepitant Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Aprepitant Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Aprepitant Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Aprepitant Sales Market Share by Country (2021-2032) Figure 38. China Aprepitant Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Aprepitant Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Aprepitant Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Aprepitant Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Aprepitant Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Aprepitant Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Aprepitant Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Aprepitant Sales Market Share by Country (2021-2032) Figure 46. Brazil Aprepitant Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Aprepitant Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Aprepitant Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Aprepitant Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Aprepitant Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Aprepitant Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Aprepitant Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Aprepitant Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Aprepitant Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Aprepitant Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Aprepitant Revenue (2021-2032) & (US$ Million) Figure 57. North America Aprepitant Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Aprepitant Revenue (2021-2032) & (US$ Million) Figure 59. Europe Aprepitant Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Aprepitant Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Aprepitant Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Aprepitant Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Aprepitant Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Aprepitant Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Aprepitant Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Oral
Applications
  • Hospital
  • Drug store
Companies covered
  • Shanghai Yingrui Biomedical Technology Co., Ltd.
  • Sandoz
  • Merck & Co.
  • Vea Impex (I) Pvt. Ltd.
  • Heron Therapeutics
  • Glenmark Pharmaceuticals
  • Aetos Pharma
  • Actiza Pharmaceutical
  • Aark Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Aprepitant Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Aprepitant Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Aprepitant Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Aprepitant Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Aprepitant Market Dynamics
  1. 2.1 Aprepitant Industry Trends
  2. 2.2 Aprepitant Industry Drivers
  3. 2.3 Aprepitant Industry Opportunities and Challenges
  4. 2.4 Aprepitant Industry Restraints
3 Aprepitant Market by Manufacturers
  1. 3.1 Global Aprepitant Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Aprepitant Sales by Manufacturers (2021-2026)
  3. 3.3 Global Aprepitant Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Aprepitant Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Aprepitant Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Aprepitant Manufacturers, Product Type & Application
  7. 3.7 Global Aprepitant Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Aprepitant Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Aprepitant Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Aprepitant Tier 1, Tier 2, and Tier 3
4 Aprepitant Market by Type
  1. 4.1 Aprepitant Type Introduction
  2. 4.1.1 Injection
  3. 4.1.2 Oral
  4. 4.2 Global Aprepitant Sales by Type
  5. 4.2.1 Global Aprepitant Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Aprepitant Sales by Type (2021-2032)
  7. 4.2.3 Global Aprepitant Sales Market Share by Type (2021-2032)
  8. 4.3 Global Aprepitant Revenue by Type
  9. 4.3.1 Global Aprepitant Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Aprepitant Revenue by Type (2021-2032)
  11. 4.3.3 Global Aprepitant Revenue Market Share by Type (2021-2032)
5 Aprepitant Market by Application
  1. 5.1 Aprepitant Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drug store
  4. 5.2 Global Aprepitant Sales by Application
  5. 5.2.1 Global Aprepitant Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Aprepitant Sales by Application (2021-2032)
  7. 5.2.3 Global Aprepitant Sales Market Share by Application (2021-2032)
  8. 5.3 Global Aprepitant Revenue by Application
  9. 5.3.1 Global Aprepitant Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Aprepitant Revenue by Application (2021-2032)
  11. 5.3.3 Global Aprepitant Revenue Market Share by Application (2021-2032)
6 Global Aprepitant Sales by Region
  1. 6.1 Global Aprepitant Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Aprepitant Sales by Region (2021-2032)
  3. 6.2.1 Global Aprepitant Sales by Region (2021-2026)
  4. 6.2.2 Global Aprepitant Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Aprepitant Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Aprepitant Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Aprepitant Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Aprepitant Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Aprepitant Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Aprepitant Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Aprepitant Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Aprepitant Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Aprepitant Revenue by Region
  1. 7.1 Global Aprepitant Revenue by Region
  2. 7.1.1 Global Aprepitant Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Aprepitant Revenue by Region (2021-2026)
  4. 7.1.3 Global Aprepitant Revenue by Region (2027-2032)
  5. 7.1.4 Global Aprepitant Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Aprepitant Revenue (2021-2032)
  8. 7.2.2 North America Aprepitant Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Aprepitant Revenue (2021-2032)
  11. 7.3.2 Europe Aprepitant Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Aprepitant Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Aprepitant Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Aprepitant Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Aprepitant Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Shanghai Yingrui Biomedical Technology Co., Ltd.
  2. 8.1.1 Shanghai Yingrui Biomedical Technology Co., Ltd. Company Information
  3. 8.1.2 Shanghai Yingrui Biomedical Technology Co., Ltd. Business Overview
  4. 8.1.3 Shanghai Yingrui Biomedical Technology Co., Ltd. Aprepitant Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Shanghai Yingrui Biomedical Technology Co., Ltd. Aprepitant Product Portfolio
  6. 8.1.5 Shanghai Yingrui Biomedical Technology Co., Ltd. Recent Developments
  7. 8.2 Sandoz
  8. 8.2.1 Sandoz Company Information
  9. 8.2.2 Sandoz Business Overview
  10. 8.2.3 Sandoz Aprepitant Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sandoz Aprepitant Product Portfolio
  12. 8.2.5 Sandoz Recent Developments
  13. 8.3 Merck & Co.
  14. 8.3.1 Merck & Co. Company Information
  15. 8.3.2 Merck & Co. Business Overview
  16. 8.3.3 Merck & Co. Aprepitant Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck & Co. Aprepitant Product Portfolio
  18. 8.3.5 Merck & Co. Recent Developments
  19. 8.4 Vea Impex (I) Pvt. Ltd.
  20. 8.4.1 Vea Impex (I) Pvt. Ltd. Company Information
  21. 8.4.2 Vea Impex (I) Pvt. Ltd. Business Overview
  22. 8.4.3 Vea Impex (I) Pvt. Ltd. Aprepitant Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Vea Impex (I) Pvt. Ltd. Aprepitant Product Portfolio
  24. 8.4.5 Vea Impex (I) Pvt. Ltd. Recent Developments
  25. 8.5 Heron Therapeutics
  26. 8.5.1 Heron Therapeutics Company Information
  27. 8.5.2 Heron Therapeutics Business Overview
  28. 8.5.3 Heron Therapeutics Aprepitant Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Heron Therapeutics Aprepitant Product Portfolio
  30. 8.5.5 Heron Therapeutics Recent Developments
  31. 8.6 Glenmark Pharmaceuticals
  32. 8.6.1 Glenmark Pharmaceuticals Company Information
  33. 8.6.2 Glenmark Pharmaceuticals Business Overview
  34. 8.6.3 Glenmark Pharmaceuticals Aprepitant Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Glenmark Pharmaceuticals Aprepitant Product Portfolio
  36. 8.6.5 Glenmark Pharmaceuticals Recent Developments
  37. 8.7 Aetos Pharma
  38. 8.7.1 Aetos Pharma Company Information
  39. 8.7.2 Aetos Pharma Business Overview
  40. 8.7.3 Aetos Pharma Aprepitant Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Aetos Pharma Aprepitant Product Portfolio
  42. 8.7.5 Aetos Pharma Recent Developments
  43. 8.8 Actiza Pharmaceutical
  44. 8.8.1 Actiza Pharmaceutical Company Information
  45. 8.8.2 Actiza Pharmaceutical Business Overview
  46. 8.8.3 Actiza Pharmaceutical Aprepitant Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Actiza Pharmaceutical Aprepitant Product Portfolio
  48. 8.8.5 Actiza Pharmaceutical Recent Developments
  49. 8.9 Aark Pharmaceuticals
  50. 8.9.1 Aark Pharmaceuticals Company Information
  51. 8.9.2 Aark Pharmaceuticals Business Overview
  52. 8.9.3 Aark Pharmaceuticals Aprepitant Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Aark Pharmaceuticals Aprepitant Product Portfolio
  54. 8.9.5 Aark Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Aprepitant Value Chain Analysis
  2. 9.1.1 Aprepitant Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Aprepitant Production Mode & Process
  6. 9.2 Aprepitant Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Aprepitant Distributors
  9. 9.2.3 Aprepitant Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst